Russia unveils ‘Altai’ neuromorphic chip to challenge US in low-power AI and defence applications
22 hours ago
Marketing software company Spotler has acquired Croatian email marketing specialist Webpower Adria, marking its third acquisition in a month and strengthening its presence in Southeast Europe, Spotler said in a press release.
Webpower Adria, a long-time reseller of Spotler products, has built a strong local brand and customer base in Croatia, Spotler said. The acquisition will allow Spotler to leverage Webpower Adria’s market knowledge and established sales network while giving customers access to the broader Spotler product suite.
“This is a natural next step in a long-standing partnership. The Webpower Adria team has always felt like part of the Spotler family, now it’s official,” Lee Chadwick, CEO of Spotler Group, said in a statement. “This move supports our ambition to deliver best-of-breed marketing tools with both global scale and strong local relevance.”
Spotler recently acquired event app software UpVisit and customer data platform Hive Marketing Cloud, signaling its strategy of expanding across the Adriatic and Southeast Europe through targeted acquisitions.
Don’t just follow the news—understand it.
The IntelliNews PRO service includes access to reports, exclusive market data, and more news that decision-makers care about. Stay ahead of the market with IntelliNews PRO.
Sign Up NowRelated Content
Tech
Russia unveils ‘Altai’ neuromorphic chip to challenge US in low-power AI and defence applications
Russia has presented a domestically developed neuromorphic processor called “Altai”, a brain-inspired chip designed to perform artificial intelligence tasks with significantly lower power consumption than conventional processors.
Polish e-commerce giant Allegro secures PLN1bn EIB facility for tech and AI push
The six-year facility for Poland's biggest e-commerce player will co-finance Allegro's strategic 2026-2030 plan to push its technological edge.
Baltic states can become a leading innovation hub in Northern Europe, foreign investors say
Despite strong potential, fragmented policies, limited access to growth capital and weak links between business and research hold the region back.
From Soviet antihistamine to Alzheimer's breakthrough: a UK biotech bets on a molecule the world forgot
A small UK-registered biotech company believes it has found an Alzheimer's treatment that is safer, cheaper and more effective than anything currently on the market — and it has done so by revisiting a molecule first synthesised by Soviet chemists.
